{"@context":"https:\/\/schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"A phase I, open-label, multicenter study to assess safety, tolerability, PK and efficacy of MK-1084 as monotherapy and in combination with pembrolizumab in subjects with KRASG12C mutant advanced solid tumors","item":"https:\/\/www.regionalcancercare.org\/trials\/a-phase-i-open-label-multicenter-study-to-assess-safety-tolerability-pk-and-efficacy-of-mk-1084-as-monotherapy-and-in-combination-with-pembrolizumab-in-subjects-with-krasg12c-mutant-advanced-solid\/#breadcrumbitem"}]}